Clinical Trials Logo

Clinical Trial Summary

Paroxysmal sympathetic hyperactivity (PSH) is a frequent symptom after traumatic brain injury and concerns up to 30% of severely brain-injured patients. PSH is due to unbalanced autonomic nervous system activity, resulting in sympathetic surges causing hypertension, tachycardia, sweating and hypertonia. The affected patients suffer more pain, more cardiovascular distress, more infections and prolonged rehabilitation and mechanical ventilation; additionally it could lead to a worse outcome. Classical music was shown to reduce autonomic nervous system imbalance in healthy people and in many medical diseases. It could be a means to dampen sympathetic surges for brain-injured patients presenting with PSH, as well. Our study aims at demonstrating that early musical intervention, started with the weaning of sedation, can reduce both the prevalence and the severity of paroxysmal sympathetic hyperactivity in traumatic brain-injured patients.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02783105
Study type Interventional
Source University Hospital, Strasbourg, France
Contact
Status Terminated
Phase N/A
Start date November 20, 2016
Completion date December 18, 2019

See also
  Status Clinical Trial Phase
Recruiting NCT05343988 - Percutaneous Neurostimulation to Treat Paroxysmal Sympathetic Hyperactivity in Children N/A
Completed NCT06090812 - Initial Volume Status in Patients With Acute Brain Injury is Associated With Neurological Prognosis
Enrolling by invitation NCT06354673 - Stellate Ganglion Block Combined With Dexmedetomidine or Subanesthetic Ketamine Infusion for Treatment of Neurostorm. N/A